Next-Generation Autonomous Urine Treatment System

Publication ID: 24-11857716_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Autonomous Urine Treatment System,” Published Technical Disclosure No. 24-11857716_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857716_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,716.

Summary of the Inventive Concept

A futuristic, AI-driven urine treatment system that combines wearable sensors, modular processing units, and decentralized data management to provide personalized, real-time treatment and monitoring.

Background and Problem Solved

The original patent's automatic urine treatment system, while innovative, has limitations in terms of real-time analysis, personalized treatment, and decentralized data management. The new inventive concept addresses these limitations by envisioning a next-generation system that leverages AI, blockchain, and wearable technologies to provide more effective, efficient, and patient-centric care.

Detailed Description of the Inventive Concept

The new inventive concept comprises a wearable, self-cleaning receiver that detects and separates urine from solid waste, and a modular, AI-powered processing unit that analyzes and treats the urine, and communicates with a remote monitoring platform. The system also includes a decentralized network of micro-treatment units, each capable of performing a specific treatment function, and a blockchain-based data management platform that tracks and verifies treatment efficacy and patient outcomes. Additionally, the system features a wearable, implantable device for continuous urine monitoring and treatment, and a virtual reality-based urine treatment simulation platform for personalized guidance and support.

Novelty and Inventive Step

The new inventive concept's use of AI, blockchain, and wearable technologies to provide real-time, personalized, and decentralized urine treatment and monitoring is a significant departure from the original patent's approach. The novel combination of these technologies enables a more efficient, effective, and patient-centric system that addresses the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different types of sensors, such as optical or electrochemical sensors, or the integration of additional treatment modalities, such as pharmacological or thermal therapies. Variations of the system could also include different types of data management platforms, such as cloud-based or edge computing architectures.

Potential Commercial Applications and Market

The next-generation autonomous urine treatment system has significant commercial potential in the healthcare industry, particularly in the areas of geriatric care, long-term care, and home healthcare. The system's ability to provide real-time, personalized, and decentralized care could also lead to cost savings and improved patient outcomes, making it an attractive solution for healthcare providers and payers.

CPC Classifications

SectionClassGroup
A A61 A61M1/80
A A61 A61F5/441
A A61 A61F5/451
G G01 G01N21/78
G G01 G01N33/493

Original Patent Information

Patent NumberUS 11,857,716
TitleAutomatic urine treatment system
Assignee(s)CRADERS Co., Ltd